242 related articles for article (PubMed ID: 23302865)
1. Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension.
Capdevila J; Wang W
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):163-9. PubMed ID: 23302865
[TBL] [Abstract][Full Text] [Related]
2. Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake.
Sun P; Antoun J; Lin DH; Yue P; Gotlinger KH; Capdevila J; Wang WH
Hypertension; 2012 Feb; 59(2):339-47. PubMed ID: 22184322
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways.
Wei Y; Lin DH; Kemp R; Yaddanapudi GS; Nasjletti A; Falck JR; Wang WH
J Gen Physiol; 2004 Dec; 124(6):719-27. PubMed ID: 15545402
[TBL] [Abstract][Full Text] [Related]
4. The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt.
Capdevila JH; Pidkovka N; Mei S; Gong Y; Falck JR; Imig JD; Harris RC; Wang W
J Biol Chem; 2014 Feb; 289(7):4377-86. PubMed ID: 24368771
[TBL] [Abstract][Full Text] [Related]
5. High potassium intake enhances the inhibitory effect of 11,12-EET on ENaC.
Sun P; Lin DH; Yue P; Jiang H; Gotlinger KH; Schwartzman ML; Falck JR; Goli M; Wang WH
J Am Soc Nephrol; 2010 Oct; 21(10):1667-77. PubMed ID: 20595684
[TBL] [Abstract][Full Text] [Related]
6. Effects of cytochrome P-450 metabolites of arachidonic acid on the epithelial sodium channel (ENaC).
Pavlov TS; Ilatovskaya DV; Levchenko V; Mattson DL; Roman RJ; Staruschenko A
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F672-81. PubMed ID: 21697242
[TBL] [Abstract][Full Text] [Related]
7. Cyp2c44 epoxygenase in the collecting duct is essential for the high K+ intake-induced antihypertensive effect.
Wang WH; Zhang C; Lin DH; Wang L; Graves JP; Zeldin DC; Capdevila JH
Am J Physiol Renal Physiol; 2014 Aug; 307(4):F453-60. PubMed ID: 24966089
[TBL] [Abstract][Full Text] [Related]
8. Epoxyeicosatrienoic acid activates BK channels in the cortical collecting duct.
Sun P; Liu W; Lin DH; Yue P; Kemp R; Satlin LM; Wang WH
J Am Soc Nephrol; 2009 Mar; 20(3):513-23. PubMed ID: 19073823
[TBL] [Abstract][Full Text] [Related]
9. Epoxyeicosatrienoic acids (EETs) regulate epithelial sodium channel activity by extracellular signal-regulated kinase 1/2 (ERK1/2)-mediated phosphorylation.
Pidkovka N; Rao R; Mei S; Gong Y; Harris RC; Wang WH; Capdevila JH
J Biol Chem; 2013 Feb; 288(7):5223-31. PubMed ID: 23283969
[TBL] [Abstract][Full Text] [Related]
10. Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid.
Wei Y; Sun P; Wang Z; Yang B; Carroll MA; Wang WH
Am J Physiol Renal Physiol; 2006 May; 290(5):F1163-8. PubMed ID: 16234312
[TBL] [Abstract][Full Text] [Related]
11. Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC.
Sun P; Lin DH; Wang T; Babilonia E; Wang Z; Jin Y; Kemp R; Nasjletti A; Wang WH
Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1192-200. PubMed ID: 16849695
[TBL] [Abstract][Full Text] [Related]
12. Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways.
Wang Z; Wei Y; Falck JR; Atcha KR; Wang WH
Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1441-7. PubMed ID: 18417544
[TBL] [Abstract][Full Text] [Related]
13. Role of epoxyeicosatrienoic acids (EETs) in mediation of dopamine's effects in the kidney.
Zhang MZ; Wang Y; Yao B; Gewin L; Wei S; Capdevila JH; Harris RC
Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1680-6. PubMed ID: 24154693
[TBL] [Abstract][Full Text] [Related]
14. Arachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevance.
Capdevila JH; Wang W; Falck JR
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():40-9. PubMed ID: 25986599
[TBL] [Abstract][Full Text] [Related]
15. Cardiac and vascular KATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms.
Lu T; Ye D; Wang X; Seubert JM; Graves JP; Bradbury JA; Zeldin DC; Lee HC
J Physiol; 2006 Sep; 575(Pt 2):627-44. PubMed ID: 16793897
[TBL] [Abstract][Full Text] [Related]
16. Epoxyeicosatrienoic acid metabolites inhibit Kir4.1/Kir5.1 in the distal convoluted tubule.
Wang MX; Wang LJ; Xiao Y; Zhang DD; Duan XP; Wang WH
Am J Physiol Renal Physiol; 2020 Jun; 318(6):F1369-F1376. PubMed ID: 32308018
[TBL] [Abstract][Full Text] [Related]
17. 5,6-epoxyeicosatrienoic acid mediates the enhanced renal vasodilation to arachidonic acid in the SHR.
Pomposiello SI; Quilley J; Carroll MA; Falck JR; McGiff JC
Hypertension; 2003 Oct; 42(4):548-54. PubMed ID: 12939232
[TBL] [Abstract][Full Text] [Related]
18. Regulation of potassium channels in coronary smooth muscle by adenoviral expression of cytochrome P-450 epoxygenase.
Campbell WB; Holmes BB; Falck JR; Capdevila JH; Gauthier KM
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H64-71. PubMed ID: 16143653
[TBL] [Abstract][Full Text] [Related]
19. Kidney CYP450 enzymes: biological actions beyond drug metabolism.
Zhao X; Imig JD
Curr Drug Metab; 2003 Feb; 4(1):73-84. PubMed ID: 12570747
[TBL] [Abstract][Full Text] [Related]
20. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
Sacerdoti D; Gatta A; McGiff JC
Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
